We collaborate with rare disease foundations, academic scientists and other companies to develop clinical candidates for rare diseases. We also collaborate with academic scientists to develop treatments for infectious diseases.
Collaborations Pharmaceuticals, Inc. offers drug discovery guidance and services tailored to rare and neglected diseases. Given our domain knowledge, we have noted the need for computational, chemical, and biological capabilities as foundations and patient-driven companies seek to translate a therapeutic concept from paper to FDA approval. We share your desire and drive to bring therapies to market.
We provide decades of drug discovery experience from concept to clinical trials. We have experience partnering with foundations and companies to find the most cost- and time-effective routes to a much needed drug therapy.
We offer computational expertise (hit discovery hit-to-lead evolution, lead optimization spanning efficacy to pharmacokinetics to toxicity issues), medicinal chemistry experience (design and synthesis of a wide array of small molecules), and biology capabilities (discovery to pre-clinical assays).
We will work with disease foundations and companies to map out strategies and manage the most expeditious and economical routes to increase the probability of successful discovery outcomes.
A key aspect of bringing a therapy to market is finding the initial funds to make this happen. We have a proven track record of small business funding through the NIH in addition to extensive contacts within the angel and venture capital worlds.
Collaborations Pharmaceuticals, Inc. shares your goal of finding a treatment and will work with you to chart a course from concept to clinic.
What we do
We develop software and approaches to streamline identification of potential therapeutics through our extensive researcher and foundation networks.
We identify research that can be readily translated to treatments for infectious diseases or rare diseases.
We provide the drug discovery preclinical and clinical expertise to move therapeutics into the clinic.